Irritable Bowel Syndrome – Nurse Practitioner

  Price  $6.95

  Credits  2

Clear


Format
Irritable bowel syndrome (IBS) is a chronic, relapsing, functional gastrointestinal (GI) disorder of the bowel that can hinder patients’ daily activities and reduce quality of life. According to the American College of Gastroenterology (ACG) an estimated 10-15% of people in the US have IBS.1,2 Women and those under 50 years of age are more likely to develop IBS than other patient populations.According to the International Foundation for Gastrointestinal Disorders (IFGD), 2 out of 3 IBS sufferers are women and in Western countries, women are 3 times more likely than men to report IBS symptoms to their providers. IBS accounts for approximately 12% of all primary care physician visits and is a common cause of referral to gastroenterologists.Direct medical costs for the management of IBS, not including prescription or over-the-counter medications,range from $1.5-10 billion annually.The indirect costs of IBS include missed workdays, low work productivity and the restriction of activities. In January 2021, ACG published updated position statements on the diagnosis and management of IBS to guide clinicians when treating and making recommendations for this group of patients.
$6.95

OR

Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Nurse Practitioner

Author
Brooke D. Fidler
PharmD, CHSE
Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

  1. List the risk factors, coexisting conditions and criteria that may be used for diagnosing irritable bowel syndrome (IBS).
  2. Recognize dietary changes and other nondrug measures that may be recommended for the management of IBS.
  3. Describe the ACG recommended prescription medications indicated for the treatment of IBS-D and IBS-C. Recognize the appropriate doses, contraindications, and side effects.
  4. Restate the ACG positions on the use of off-label and nonprescription medications in the management of IBS-D and IBS-C.

Course Accreditation

  • Activity Type:
    Knowledge
  • CE Broker
    20-889178
  • Universal Activity Number:
    Nurse Practitioner : 0798-0000-21-276-H01
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

In order to obtain a Statement of Credit, attendees must answer poll questions where presented and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.